Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
about
Inhibitor-Based Therapeutics for Treatment of Viral HepatitisInhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytesSafety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B InfectionTreatment of hepatitis B virus: an update.The current status and future directions of hepatitis B antiviral drug discovery.Review article: novel therapies for hepatitis B virus cure - advances and perspectives.Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.Performance Characteristics of a New Consensus Commercial Kit for Hepatitis D Virus RNA Viral Load Quantification.First international external quality assessment for hepatitis delta virus RNA quantification in plasma.Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.Activity of nucleic acid polymers in rodent models of HBV infection.Nucleic acid polymer REP 2139 and nucleos(t)ide analogues act synergistically against chronic hepadnaviral infection in vivo.
P2860
Q28073697-0C2AEFC2-D7B0-4E7D-921B-01E0C6A11EBCQ33821878-F0FB82E4-C366-49A3-AFA4-ECEF6B29852BQ36039553-16A1EE07-A3C7-4C25-889A-74D9DF15304FQ38794446-D220C125-CC4A-474F-ADA6-8E650522A984Q38802098-B6B157C0-7F39-44B6-8C78-B848039A29A2Q38865511-DBC822E3-2F0C-41D6-BD6E-DBF45ADA0F31Q39414876-160C619A-BBB2-44A3-BDE1-A702F97AACDDQ40302798-AE0B0C42-7EBA-45B5-B2EE-8FBA84EC18B2Q40437975-45E0400C-3C7D-4717-9696-2AC06218C4A7Q40496079-8D691247-88BF-4156-B37D-74343360DE44Q42209643-F60D82C3-4C24-418C-A68A-0220D80B12F8Q45323707-44A0C762-B7C8-4BBA-946A-F37F94AF958EQ46263692-BA51AE87-1861-4E6C-A3A7-F82C078DEB9FQ47564306-7D6E2334-57BE-4A2D-80DB-2A7F1A67B426
P2860
Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic Antiviral Effect o ...... k Hepatitis B Virus Infection.
@ast
Therapeutic Antiviral Effect o ...... k Hepatitis B Virus Infection.
@en
type
label
Therapeutic Antiviral Effect o ...... k Hepatitis B Virus Infection.
@ast
Therapeutic Antiviral Effect o ...... k Hepatitis B Virus Infection.
@en
prefLabel
Therapeutic Antiviral Effect o ...... k Hepatitis B Virus Infection.
@ast
Therapeutic Antiviral Effect o ...... k Hepatitis B Virus Infection.
@en
P2093
P2860
P1433
P1476
Therapeutic Antiviral Effect o ...... k Hepatitis B Virus Infection.
@en
P2093
Andrew Vaillant
Arend Grosse
Behzad B Ajilian
Catherine A Scougall
Faseeha Noordeen
Georget Reaiche-Miller
Joerg F Schlaak
John Finnie
Melanie Werner
P2860
P304
P356
10.1371/JOURNAL.PONE.0140909
P407
P577
2015-11-11T00:00:00Z